Delcath Systems Inc (DCTH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Delcath Systems Inc (DCTH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7070
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Delcath Systems Inc (Delcath) specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient’s bloodstream. The company develops formulations for use with the Delcath Hepatic Delivery System (Melphalan/HDS) and to administer high dose chemotherapy to the liver. The company sells its proprietary system to deliver and filter melphalan hydrochloride in Europe under the trade name, Delcath Hepatic Chemosat Delivery System for Melphalan (Chemosat). Delcath is headquartered in New York, the US.

Delcath Systems Inc (DCTH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Delcath Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Delcath Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Delcath Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Delcath Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Delcath Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Delcath Systems Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Delcath Systems Raises USD8.1 Million in Rights Offering of Shares 10
Delcath Systems Plans to Raise up to USD6 Million in Public Offering of Shares 12
Delcath Systems Files Registration Statement for Public Offering of Units for up to USD10 Million 13
Delcath Systems Raises USD5 Million in Public Offering of Units 14
Delcath Systems to Raise USD2.4 Million in Private Placement of Series B Preferred Shares 15
Delcath Systems Raises USD1.3 Million in Public Offering Shares and Warrants 16
Delcath Systems Raises USD7 Million in Public Offering of Units 17
Delcath Systems Raises USD3 Million in Public Offering of Shares and Warrants 19
Delcath Systems to Raise Additional USD6 Million in Public Offering of Shares 21
Delcath Systems Completes Public Offering Of Shares For US$7.5 Million 22
Delcath Systems Completes Private Placement Of Shares For US$2 Million 23
Delcath Systems Completes Public Offering Of Units For US$23 Million 24
Delcath Systems Completes Second Tranche Of Private Placement Of Shares For US$1.2 Million 25
Debt Offering 27
Delcath Systems Raises USD1.7 Million in Private Placement of 8% Notes 27
Delcath Systems Raises USD0.57 Million in Private Placement of 8% Notes Due 2019 28
Delcath Systems Inc – Key Competitors 29
Delcath Systems Inc – Key Employees 30
Delcath Systems Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Aug 15, 2018: Delcath announces second quarter fiscal 2018 financial results 32
May 10, 2018: Delcath Announces First Quarter 2018 Financial Results 34
Mar 16, 2018: Delcath Announces 2017 Financial Results 36
Nov 14, 2017: Delcath Announces Third Quarter 2017 Financial Results 39
Aug 08, 2017: Delcath Announces Second Quarter 2017 Financial Results 41
May 09, 2017: Delcath Announces First Quarter 2017 Financial Results 43
Mar 29, 2017: Delcath Announces 2016 Financial Results 44
Legal and Regulatory 46
Sep 14, 2017: Delcath Announces Accelerated Listing on OTCQB 46
Sep 13, 2017: Delcath Announces Relisting on OTCQB 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Delcath Systems Inc, Medical Equipment, Key Facts, 2017 2
Delcath Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Delcath Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Delcath Systems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Delcath Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Delcath Systems Inc, Deals By Market, 2012 to YTD 2018 8
Delcath Systems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Delcath Systems Raises USD8.1 Million in Rights Offering of Shares 10
Delcath Systems Plans to Raise up to USD6 Million in Public Offering of Shares 12
Delcath Systems Files Registration Statement for Public Offering of Units for up to USD10 Million 13
Delcath Systems Raises USD5 Million in Public Offering of Units 14
Delcath Systems to Raise USD2.4 Million in Private Placement of Series B Preferred Shares 15
Delcath Systems Raises USD1.3 Million in Public Offering Shares and Warrants 16
Delcath Systems Raises USD7 Million in Public Offering of Units 17
Delcath Systems Raises USD3 Million in Public Offering of Shares and Warrants 19
Delcath Systems to Raise Additional USD6 Million in Public Offering of Shares 21
Delcath Systems Completes Public Offering Of Shares For US$7.5 Million 22
Delcath Systems Completes Private Placement Of Shares For US$2 Million 23
Delcath Systems Completes Public Offering Of Units For US$23 Million 24
Delcath Systems Completes Second Tranche Of Private Placement Of Shares For US$1.2 Million 25
Delcath Systems Raises USD1.7 Million in Private Placement of 8% Notes 27
Delcath Systems Raises USD0.57 Million in Private Placement of 8% Notes Due 2019 28
Delcath Systems Inc, Key Competitors 29
Delcath Systems Inc, Key Employees 30
Delcath Systems Inc, Other Locations 31
Delcath Systems Inc, Subsidiaries 31

List of Figures
Delcath Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Delcath Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Delcath Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Delcath Systems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Delcath Systems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Delcath Systems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Delcath Systems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Delcath Systems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Delcath Systems Inc (DCTH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Massy United Insurance Ltd:企業の戦略的SWOT分析
    Massy United Insurance Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nippon Soda Co., Ltd. (4041):企業の財務・戦略的SWOT分析
    Nippon Soda Co., Ltd. (4041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hana Financial Group Inc.:企業の戦略・SWOT・財務分析
    Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Hana Financial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • BioAtla LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary BioAtla LLC (BioAtla) is a biotechnology company that develops novel monoclonal antibodies and other cell based therapeutics. The company utilizes proprietary conditionally active biologics and comprehensive integrated antibody optimization platforms to develop novel therapies. It develops d …
  • Harley-Davidson Inc (HOG):企業の財務・戦略的SWOT分析
    Harley-Davidson Inc (HOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Terumo Cardiovascular Systems Corp:企業の戦略的SWOT分析
    Terumo Cardiovascular Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Housing Development Finance Corporation Ltd:企業のM&A・事業提携・投資動向
    Housing Development Finance Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Housing Development Finance Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • CBRE Global Investors LLC:企業の戦略的SWOT分析
    CBRE Global Investors LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Moximed Inc:医療機器:M&Aディール及び事業提携情報
    Summary Moximed Inc (Moximed), formerly ExploraMed NC4, Inc. focuses to develop unicompartmental load absorber implants for patients with painful knee osteoarthritis (OA). The company provides Atlas Knee System, an implantable knee joint unloader which works as a shock absorber for pre-arthroplasty …
  • Arthur J. Gallagher & Co:戦略・SWOT・企業財務分析
    Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report Summary Arthur J. Gallagher & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Datang International Power Generation Co Ltd:発電所・企業SWOT分析
    Datang International Power Generation Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • PT Indo Tambangraya Megah Tbk:企業の戦略・SWOT・財務情報
    PT Indo Tambangraya Megah Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Indo Tambangraya Megah Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Novo Nordisk AS (NOVO B)-製薬・医療分野:企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Bell Helicopter Textron Inc.:企業の戦略・SWOT・財務情報
    Bell Helicopter Textron Inc. - Strategy, SWOT and Corporate Finance Report Summary Bell Helicopter Textron Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • EnPro Industries, Inc.:企業のM&A・事業提携・投資動向
    EnPro Industries, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnPro Industries, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Oil States International, Inc.:企業の戦略・SWOT・財務情報
    Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • genOway SA (ALGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary genOway SA (genOway) is a biotechnology company that develops genetically modified mouse, rat and cellular models for pharmaceutical companies and research institutes. The company develops several technology platforms such as safe DNA transgenesis, quick knock-in, safe in vivo RNAi and safe …
  • EDF Energies Nouvelles SA:電力:M&Aディール及び事業提携情報
    Summary EDF Energies Nouvelles SA (EDF Energies Nouvelles) a subsidiary of Electricite de France S.A., develops, constructs, operates and maintains green electricity power plants in Europe and North America. The company produces electricity through various renewable energy sources such as wind, sola …
  • Proton Holdings Berhad:企業の戦略的SWOT分析
    Proton Holdings Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆